CPB in High-Risk Groups: CPB in Diabetics

Abstract

Get full access to this article

View all access options for this article.

References

Santos JMG , Ruiz MC. Coronary artery surgery in diabetic patients . Rev Esp Cardiol 2002; 55: 1311-1322 .

BARI . Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease. The Bypass Angioplasty Revascularization investigation . Circ J 1997; 96: 1761-1769 .

Herlitz J , Malmberg K , Karlson BW , et al. Mortality and morbidity during a five-year follow-up in diabetics with myocardial infarction . Acta Med Scand 1998; 244: 31-38 .

Herlitz J , Wongsen GB , Karlson BW , et al. Mortality, mode of death and risk indicators for death during 5 years after coronary artery bypass grafting among patients with and without a history of diabetes mellitus . Coron Artery Dis 2000; 11: 339-346 .

Szabo Z , Håkanson E , Svedjeholm R. Early postoperative outcome and medium-term survival in 540 diabetic and 2239 nondiabetic patients undergoing coronary artery bypass grafting . Ann Thorac Surg 2002; 74: 712-719 .

Cariou B , Bonnevie L , Mayaudon H. Angiographic characteristics of coronary artery disease in diabetic patients compared with matched non-diabetic subjects . Diabetes Nutr Metab 2000; 13: 134-141 .

Jones RH , Hannan EL , Hammermeister KE , et al. Identification of preoperative variables needed for risk adjustment of short-term mortality after coronary artery bypass graft surgery. The working group panel on the cooperative CABG database project . Am Coll Cardiol 1996; 28: 1478-1487 .

Mangano CM , Diamondstone LS , Ramsay JG , et al. Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization. The Multicenter Study of Perioperative Ischemia Research Group . Ann Intern Med 1998; 128: 194-203 .

Herzog CA , Ma JZ , Collins AJ. Comparative survival of dialysis patients in the United States after coronary angioplasty, coronary artery stenting, and coronary artery bypass surgery and impact of diabetes . Circ J 2002; 106: 2207-2211 .

10.

Kadoi Y , Saito S , Fuijta N , et al. Risk factors for cognitive dysfunction after coronary artery bypass graft surgery in patients with type 2 diabetes . J Thorac Cardiovasc Surg 2005; 129: 576-583 .

11.

Zerr KJ , Furnary AP , Grunkemeier GL , Bookin S , Kanhere V , Starr A. Glucose control lowers the risk of wound infection in diabetics after open heart operation . Ann Thorac Surg 1997; 63: 356-361 .

12.

Black CT , Hennessey PJ , Andrassy RJ. Short-term hyperglycemia depresses immunity through nonenzymatic glycocylation of circulating immunoglobulin . J Trauma 1990; 30: 830-832 .

13.

Furnary AP , Guangqiang G , Grunkemeier GL , et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary bypass grafting . J Thorac Cardiovasc Surg 2003; 125: 1007-1007 .

14.

van den Berghe G , Wouters P , Weekers F , et al. Intensive insulin therapy in critically ill patients . New Engl J Med 2001; 19: 1359-1367 .

15.

Gustafson PA. Conventional approach to glucose management for diabetic patients undergoing coronary artery bypass surgery . Perfusion 2002; 17: 141-144 .

16.

Zindrou D , Taylor KM , Peder Bagger J. Admission plasma glucose: an independent risk factor in nondiabetic women after coronary artery bypass grafting . Diabetes Care 2001; 24: 16-34 .

17.

Stevens LM , Carrier M , Perrault LP , et al. Influence of diabetes and bilateral internal thoracic artery grafts on long-term outcome for multivessel coronary artery bypass grafting . Eur J Cardiothorac Surg 2005; 27: 281-288 .

18.

Anderson RE , Brismar K , Barr G , Ivert T. Effects of cardiopulmonary bypass on glucose homeostasis after coronary artery bypass surgery . Eur J Cardiothorac Surg 2005; 28: 425-430 .

19.

Lehle K , Mü nzel D , Hauber F. Development of a patient specific model to evaluate the endothelial dysfunction in patients with non-insulin diabetes mellitus (NIDDM) . Naunyn-Schmiedeberg’s Arch Pharmacol 2006; 372 Suppl 1: 540-540 .

20.

Haubner F , Lehle K , Mü nzel D. Differences between HUVEC and HSVEC concerning the effect of high glucose on proliferation and inflammatory response . Naunyn-Schmiedeberg’s Arch Pharmacol 2006; 372 Suppl 1: 543-543 .